MHRA has approved imlunestrant tosylate (Inluriyo) for a defined group of adults with ER-positive, HER2-negative locally advanced or metastatic...
Read MoreA new strategic licensing agreement between THX Pharma and Biocodex is aiming to push forward two experimental programmes across...
Read MoreBioxytran has reported positive results from a completed Phase 2 trial of its investigational antiviral candidate, ProLectin-M, pointing to...
Read MoreKahimmune Therapeutics has signed an exclusive licensing agreement with Gustave Roussy and Société d’Accélération du Transfert de Technologies (SATT)...
Read MoreEn Carta Diagnostics, a start-up focused on molecular diagnostics kits, has announced that its EC Pocket Lyme test has...
Read MoreENA Respiratory has started dosing participants in a phase 2 community study of INNA-051, a dry-powder nasal spray being...
Read More